Prescription Drugs
Maine 128th Legislature
An Act To Change the Procedures for Veterinarians in the Controlled Substances Prescription Monitoring Program [SB-1730]
An Act To Change the Procedures for Veterinarians in the Controlled Substances Prescription Monitoring Program
Sponsored by: Sen. James Hamper
Passed To Be Enacted, In Concurrence. on 04/03/2018
Spread the world
Gettr
US Congress 115th Congress
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes. [HB-4392]
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes. This bill nullifies a rule finalized by the Centers for Medicare & Medicaid Services on November 13, 2017, that modifies payment under Medicare for certain drugs purchased through the
(continued...)
Sponsored by: Rep. Alexander Mooney
Referred To The Subcommittee On Health. on 11/17/2017
Spread the world
US Congress 115th Congress
Addiction Treatment Access Improvement Act of 2017 [HB-3692]
Addiction Treatment Access Improvement Act of 2017 This bill amends the Controlled Substances Act to revise the qualifications required for a practitioner to administer, dispense, or prescribe narcotic drugs for maintenance or detoxification treatment in an office-based opioid treatment program. It increases the maximum patient limit for a qualifying practitioner who meets certain requirements. The maximum patient limit is the maximum number of patients a qualifying practitioner can treat at one time. The bill expands qualifying practitioners to
(continued...)
Sponsored by: Rep. Barbara Comstock
Subcommittee Consideration And Mark-up Session Held. on 04/25/2018
Spread the world
US Congress 115th Congress
Every Prescription Conveyed Securely Act [HB-3528]
Every Prescription Conveyed Securely Act This bill generally requires, with specified exceptions, electronic prescribing under the Medicare prescription drug benefit with respect to covered drugs that are controlled substances.
Sponsored by: Rep. Dina Titus
Reported (amended) By The Committee On Energy And Commerce. H. Rept. 115-748, Part I. on 06/12/2018
Spread the world
US Congress 115th Congress
FACTS Act of 2017 Furthering Access to Coordinated Treatment for Seniors Act of 2017 [HB-3447]
FACTS Act of 2017 Furthering Access to Coordinated Treatment for Seniors Act of 2017 This bill amends title XVIII (Medicare) of the Social Security Act to allow Medicare prescription drug plan (PDP) sponsors to access certain Medicare claims data. Specifically, the Centers for Medicare & Medicaid Services (CMS) must establish a process for PDP sponsors to request, beginning in plan year 2020, standardized extracts of claims data for Medicare hospital and medical services. PDP sponsors may use such data: (1) to optimize therapeutic outcomes through
(continued...)
Sponsored by: Rep. Earl Blumenauer
Referred To The Subcommittee On Health. on 07/28/2017
Spread the world
US Congress 115th Congress
Opioid and Heroin Abuse Crisis Investment Act of 2017 [HB-3495]
Opioid and Heroin Abuse Crisis Investment Act of 2017 This bill amends the 21st Century Cures Act to make appropriations for FY2019-FY2023 for state grants to address the opioid abuse crisis. States receiving a grant must report on substance abuse services provided to underserved populations, including Native Americans.
Sponsored by: Rep. Sean Maloney
Referred To The Subcommittee On Health. on 07/28/2017
Spread the world
US Congress 115th Congress
Safer Prescribing of Controlled Substances Act [S.1554]
Safer Prescribing of Controlled Substances Act
Sponsored by: Sen. Dianne Feinstein
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 07/13/2017
Spread the world
US Congress 115th Congress
Orphan Products Extension Now Accelerating Cures and Treatments Act of 2017 [S.1509]
Orphan Products Extension Now Accelerating Cures and Treatments Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to extend by six months the exclusivity period for an approved drug or biological product when the product is additionally approved to prevent, diagnose, or treat a new indication that is a rare disease or condition (also known as an orphan disease). The FDA may revoke an extension if the application for the new indication contained an untrue material statement. The
(continued...)
Sponsored by: Sen. Robert Menendez
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 06/29/2017
Spread the world
US Congress 115th Congress
Tax Cuts and Jobs Act [HB-1]
Tax Cuts and Jobs Act This bill amends the Internal Revenue Code (IRC) to reduce tax rates and modify policies, credits, and deductions for individuals and businesses. It also establishes an oil and gas leasing program for the Coastal Plain of the Arctic National Wildlife Refuge (ANWR) in Alaska. (Unless otherwise specified, provisions referred to in this summary as temporary or as a suspension of an existing provision apply for taxable years beginning after December 31, 2017, and before January 1, 2026.) TITLE I Subtitle A-- Individual Tax Reform
(continued...)
Sponsored by: Rep. Tom Rice
Signed By President. on 12/22/2017
Spread the world
US Congress 115th Congress
SUPPORT for Patients and Communities Act Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act [HB-6]
SUPPORT for Patients and Communities Act Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act TITLE I--MEDICAID PROVISIONS TO ADDRESS THE OPIOID CRISIS (Sec. 1001) The bill prohibits termination of Medicaid eligibility for juveniles who are inmates of public institutions. (Sec. 1003) The Centers for Medicare & Medicaid Services (CMS) must establish a demonstration project to increase provider treatment capacity for substance-use disorders. (Sec. 1004) State Medicaid programs must establish
(continued...)
Sponsored by: Rep. Ann Kuster
Became Public Law No: 115-271. on 10/24/2018
Spread the world
US Congress 115th Congress
Patients' Access to Treatments Act of 2017 [HB-2999]
Patients' Access to Treatments Act of 2017 This bill amends the Public Health Service Act to establish cost sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost sharing structure. Such health plans may not impose higher cost sharing requirements, including copayment and coinsurance, for specialty drugs than for other prescription drugs in a nonpreferred brand name drug tier. If a health plan's formulary contains more than one nonpreferred brand name drug tier, the tier with the lowest cost sharing
(continued...)
Sponsored by: Rep. Gerald Connolly
Referred To The Subcommittee On Health. on 06/23/2017
Spread the world
US Congress 115th Congress
Stop Price Gouging Act [HB-2974]
Stop Price Gouging Act This bill amends the Internal Revenue Code to impose an excise tax on pharmaceutical companies that sell prescription drugs that are subject to price spikes that exceed the annual percentage increase in the medical care consumer price index detailed expenditure category for all urban consumers (U.S. city average). For each taxable prescription drug, the excise tax ranges from 50% to 100% of price spike revenue received by the company, depending on the size of the price spike and including an adjustment for revenue that is
(continued...)
Sponsored by: Rep. Pramila Jayapal
Referred To The Subcommittee On Health. on 06/23/2017
Spread the world
US Congress 115th Congress
Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2017 RxCAP Act of 2017 [S.1347]
Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2017 RxCAP Act of 2017 This bill amends title XVIII (Medicare) of the Social Security Act to eliminate beneficiary cost-sharing above the Medicare prescription benefit's annual out-of-pocket threshold beginning in plan year 2018. Under current law, the Medicare prescription drug benefit provides coverage above that threshold only with cost-sharing in the form of either copayment or coinsurance.
Sponsored by: Sen. Ron Wyden
Read Twice And Referred To The Committee On Finance. on 06/13/2017
Spread the world
US Congress 115th Congress
Closing Loopholes for Orphan Drugs Act [HB-2889]
Closing Loopholes for Orphan Drugs Act This bill amends the Public Health Service Act to revise the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program.
Sponsored by: Rep. Collin Peterson
Referred To The Subcommittee On Health. on 06/16/2017
Spread the world
US Congress 115th Congress
Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 [S.1348]
Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 This bill amends title XI (General Provisions) of the Social Security Act to require manufacturers of drugs with specified percentage increases in their wholesale costs to submit to the Centers for Medicare & Medicaid Services (CMS) written justification for certain increases in drug prices. The CMS shall publish each submission, together with an easily understandable summary, on its website. Certain proprietary information may be excluded from publication, as
(continued...)
Sponsored by: Sen. Ron Wyden
Read Twice And Referred To The Committee On Finance. on 06/13/2017
Spread the world
US Congress 115th Congress
Preserving Patient Access to Compounded Medications Act of 2017 [HB-2871]
Preserving Patient Access to Compounded Medications Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to expand the circumstances under which a drug may be compounded (manufactured at small scale) to allow pharmacists and physicians to compound drugs for administration to patients in an office or clinical setting, in accordance with state law. (Drugs that are compounded do not need to meet certain federal requirements regarding manufacturing, labeling, or approval.) Dietary supplements may be used in the compounding of a drug.
(continued...)
Sponsored by: Rep. Mike Johnson
Referred To The Subcommittee On Health. on 06/16/2017
Spread the world
US Congress 115th Congress
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes. [S.1304]
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes. This bill modifies the methodology used to calculate a manufacturer's average sales price for certain drugs covered under Medicare. Specifically, the bill excludes, from a manufacturer's average sales price calculation, customary prompt pay discounts extended to wholesalers.
Sponsored by: Sen. Robert Casey
Read Twice And Referred To The Committee On Finance. on 06/07/2017
Spread the world
US Congress 115th Congress
Veteran Overmedication Prevention Act of 2017 [HB-2652]
Veteran Overmedication Prevention Act of 2017 This bill requires the Department of Veterans Affairs (VA) to contract with the National Academies of Sciences, Engineering, and Medicine to review the deaths of all covered veterans who died by suicide during the last five years, regardless of whether information relating to such deaths has been reported by the Centers for Disease Control and Prevention. A "covered veteran" is any veteran who received VA hospital care or medical services during the five-year period preceding the veteran's death. The
(continued...)
Sponsored by: Rep. Mike Johnson
Introduced In House on 05/25/2017
Spread the world
Arizona Fifty-third Legislature - First Regular Session (2017)
Drug overdose; review team; confidentiality [HB-2493]
Drug overdose; review team; confidentiality
Sponsored by: Rep. Heather Carter
Chapter 234 on 05/01/2017
Spread the world
Arizona Fifty-third Legislature - First Regular Session (2017)
Prescription drugs; delivery; pricing; appeals [SB-1436]
Prescription drugs; delivery; pricing; appeals
Sponsored by: Sen. Nancy Barto
Senate Hhs Committee Action: Failed To Pass, Voting: (3-4-0-0) on 02/15/2017